~~<i id='5C3D796109'><strike id='5C3D796109'><tt id='5C3D796109'><pre id='5C3D796109'></pre></tt></strike></i>~~

Home» Wikipedia» entertainment

entertainment

author：knowledge 2025-10-06 12:46:58 Page View：71

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： A strong 6.5
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

explore

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

DarronCummings/APTheFoodandDrugAdministrationonThursdayapprovedanEliLillydrugthattakesanewapproachto

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

3:01NationalParkServiceRangersGiaPonce(L)andChristinaCaparelliarephotographedbyRangerNicoleBernardne

WSS

entertainment

entertainment

comprehensive

explore

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit